Focal Segmental Glomerulosclerosis (FSGS) Withdrawn Phase Trials for Tacrolimus (DB00864)

Also known as: Focal Glomerulosclerosis / Glomerulosclerosis, Focal / Focal Segmental Glomerulosclerosis / Glomerulosclerosis, Focal Segmental / APOL1-mediated focal segmental glomerulosclerosis / Focal & segmental glomerulosclerosis / Focal glomerular sclerosis (disorder) / Focal segmental glomerulosclerosis (disorder)

IndicationStatusPhase
DBCOND0038485 (Focal Segmental Glomerulosclerosis (FSGS))WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00302536Tacrolimus Treatment of Patients With Idiopathic Focal Segmental GlomerulosclerosisTreatment